STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

TCRR TCR2 THERAPEUTICS INCORPORATED StockScouter® Report

8

StockScouter® Score

TCR2 THERAPEUTICS INCORPORATED, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • An executive, director or major shareholder purchased a large number of shares recently. Postive/Neutral
  • Moving average analysis for TCRR suggests upward price movement over the medium term. Positive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 100% done.
Low
High

Core Model Grades

F
A
N/A
A

Previous Ratings

4
4
7